Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - Recro Pharma, Inc. | reph-ex321_9.htm |
| EX-31.3 - EX-31.3 - Recro Pharma, Inc. | reph-ex313_101.htm |
| EX-31.2 - EX-31.2 - Recro Pharma, Inc. | reph-ex312_15.htm |
| EX-31.1 - EX-31.1 - Recro Pharma, Inc. | reph-ex311_17.htm |
| EX-23.1 - EX-23.1 - Recro Pharma, Inc. | reph-ex231_8.htm |
| EX-10.38 - EX-10.38 - Recro Pharma, Inc. | reph-ex1038_282.htm |
| EX-10.20 - EX-10.20 - Recro Pharma, Inc. | reph-ex1020_281.htm |
| EX-5.1 - EX-5.1 - Recro Pharma, Inc. | reph-ex51_283.htm |
| EX-4.8 - EX-4.8 - Recro Pharma, Inc. | reph-ex48_284.htm |
| 10-K - 10-K - Recro Pharma, Inc. | reph-10k_20171231.htm |
Exhibit 21.1
LIST OF SUBSIDIARIES
|
Subsidiary |
|
Ownership |
|
|
Jurisdiction of |
|
|
Recro Gainesville LLC |
|
|
100 |
% |
|
Massachusetts |
|
Recro Enterprises, Inc. |
|
|
100 |
% |
|
Delaware |
|
Recro Ireland Limited |
|
|
100 |
% |
|
Ireland |